Jordi Remon, Coordinator of the Cancer Medicine Department at CIOCC Barcelona – HM Nou Delfos, shared a post on X:
“In this ASCO Educational Book we summarize in EGFR mutated lung cancer:
- New EGFR TKI options in early stage.
- New options in metastatic setting.
- Mechanisms of acquired resistance and new drugs.
Online at ASCOPubs.
Thanks to Stephanie Saw, Xiuning Le, Lizza Hendriks.”
Source: Jordi Remon/X
